Giant Cell Arthritis

Largest, most representative GCA data registry available for licensing, analytics, and collaboration

Research-Grade RWD in GCA

Unmet Need

Disease with no cure

With no cure for GCA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.

Deep Clinical Data

7,100+*

GCA patients followed prospectively with deep clinical, lab, and other linked data

*Counts are based on Q2 2023 registry release

Analytics & Modeling

70,600+*

GCA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes

Why OM1 GCA?

Sample Use Cases

» Feasibility	» Comparative Effectiveness
» Passive Safety	» Natural History

Webinar: Real-World Data for R&D for Autoimmune & Chronic Diseases

Infosheet

Learn about the OM1 GCA Registry:

Abstract & Publications

Poster (ACR/ARHP 2017): Treatment Patterns in Large Vessel Arteritis (Giant Cell Arteritis and Temporal Arteritis): Findings from a Large Contemporaneous Real-World Cohort in the US

Request a Meeting

Name*
First Last
Company Name*
Job Title*
Email*
Message*
Comments
This field is for validation purposes and should be left unchanged.